Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.59
+7.67 (2.59%)
At close: Jun 26, 2026, 4:00 PM EDT
303.00
-0.59 (-0.19%)
After-hours: Jun 26, 2026, 5:54 PM EDT
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$5,839,915
Profits / Employee
$3,267,213
Market Cap
6.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
LGND News
- 2 days ago - Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewsWire
- 5 days ago - Ligand prices upsized $625M convertible senior note offering - TheFly
- 5 days ago - Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering - GlobeNewsWire
- 6 days ago - Ligand files to sell $550M of convertible senior notes due 2031 - TheFly
- 6 days ago - Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031 - GlobeNewsWire
- 18 days ago - Ligand Announces 2026 Investor Day in New York City - GlobeNewsWire
- 4 weeks ago - Ligand price target raised to $266 from $263 at BofA - TheFly
- 4 weeks ago - Ligand to Participate in June Investor Conferences - GlobeNewsWire